LeaderPortfolio
Braun
Ludwig Theodor Braun
Rank #2434
GERMANYHealthcareMedical technology

Ludwig Theodor Braun

Net Worth
$1.649B
0% (24h)
Ludwig Theodor Braun, a German citizen born in 1990, is a prominent figure in the healthcare industry. He is known for his significant ownership stake in B. Braun Melsungen, a leading medical technology company. With a net worth of $1.53 billion as of March 11, 2026, Braun's wealth stems from his family's long-standing involvement in the medical device sector. His career reflects a commitment to innovation and the advancement of healthcare solutions. Braun's influence extends beyond his personal wealth, as he is part of a family that has shaped the medical technology landscape for generations. His residence is in Melsungen, Germany.

How to read Ludwig Theodor Braun's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Ludwig Theodor Braun, we anchor the narrative to Medical technology and Medical technology, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $1.649B alongside global rank #2434, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (GERMANY) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Ludwig Theodor Braun, born in 1990, is a scion of the Braun family, deeply rooted in the medical technology industry. His family's legacy began in 1839 when Julius Wilhelm Braun purchased a pharmacy in Melsungen, Germany. The family business evolved over generations, expanding into the manufacturing of medical products. Ludwig Theodor Braun represents the sixth generation of family involvement in the company.

Rise to Success

Braun's success is directly linked to his ownership in B. Braun Melsungen AG. The company, founded by his ancestors, has grown into a global leader in medical technology, manufacturing a wide range of products. The company's annual revenue was €8.75 billion as of December 31, 2023. Ludwig Theodor's father, Ludwig Georg Braun, transformed the company into a major manufacturer of medical products. Anna Maria Braun, his sister, is the CEO of B. Braun.

Key Business Strategies

The company's strategies involve continuous innovation, efficiency, and sustainability. B. Braun focuses on providing solutions to healthcare professionals, with a commitment to improving patient care and outcomes. The company's operations include four divisions: Hospital Care, Aesculap, OPM (outpatient market), and Avitum. The company has expanded its operations to over 60 countries.

Philanthropy

B. Braun supports several initiatives, including the “B. Braun for Children” program, which aims to improve the long-term prospects of children. Specific amounts of philanthropic contributions are not readily available, but the company’s commitment to social responsibility is evident in its support for various causes.

Career Timeline

2011

Family Leadership Transition

The generation of Ludwig Georg Braun stepped down, and Ludwig Theodor's generation assumed leadership roles within the B. Braun group.

Philanthropic Impact

Child welfareNot Available

B. Braun for Children

Activities were promoted to improve the long-term prospects of children.

Key Business Ventures & Holdings

CompanyStakeValue
B. Braun Melsungen AG10.00%

Net Worth History

In-Depth Analysis

Early Life

Ludwig Theodor Braun, born in 1990, is a scion of the Braun family, deeply rooted in the medical technology industry. His family's legacy began in 1839 when Julius Wilhelm Braun purchased a pharmacy in Melsungen, Germany. The family business evolved over generations, expanding into the manufacturing of medical products. Ludwig Theodor Braun represents the sixth generation of family involvement in the company.

Rise to Success

Braun's success is directly linked to his ownership in B. Braun Melsungen AG. The company, founded by his ancestors, has grown into a global leader in medical technology, manufacturing a wide range of products. The company's annual revenue was €8.75 billion as of December 31, 2023. Ludwig Theodor's father, Ludwig Georg Braun, transformed the company into a major manufacturer of medical products. Anna Maria Braun, his sister, is the CEO of B. Braun.

Key Business Strategies

The company's strategies involve continuous innovation, efficiency, and sustainability. B. Braun focuses on providing solutions to healthcare professionals, with a commitment to improving patient care and outcomes. The company's operations include four divisions: Hospital Care, Aesculap, OPM (outpatient market), and Avitum. The company has expanded its operations to over 60 countries.

Philanthropy

B. Braun supports several initiatives, including the “B. Braun for Children” program, which aims to improve the long-term prospects of children. Specific amounts of philanthropic contributions are not readily available, but the company’s commitment to social responsibility is evident in its support for various causes.

Data Sources & Methodology

Figures for Ludwig Theodor Braun are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.